From Triumph to Tomorrow: Bakery China 2025 Wraps Up, Prepares for Next Chapter
SHANGHAI, May 27, 2025 /PRNewswire/ -- Bakery China 2025 concluded its record-setting four-day run on May 22, 2025 at the National Exhibition and Convention Center (NECC) in Shanghai, reaffirming its status as the leading international event for...
IMAGICA GROUP Film Project: "Maria" Selected by Film Professionals Including Film Director Hirokazu Kore-eda at 78th Cannes Film Festival
TOKYO, May 27, 2025 /PRNewswire/ -- IMAGICA GROUP Inc., headquartered in Tokyo, launched the IMAGICA GROUP Film Project as a new challenge to celebrate its 90th anniversary in 2025. The outline of the project, which will be the company's first...
China-Europe-America Global Initiative Think Tanks and Museums Paris Dialogue 2025 Held in Paris
PARIS, May 26, 2025 /PRNewswire/ -- On May 23, the China-Europe-America Global Initiative Think Tanks and Museums Paris Dialogue 2025 was held in Paris, with more than 50 guests from China, France, Italy, the US and other countries engaged in the...
Where Luxury Meets Local: "Heartbeat of a Destination" by the Luxury Group by Marriott International Celebrates Greater China Hotels Immersed in the Spirit of Place
SHANGHAI, May 26, 2025 /PRNewswire/ -- Luxury Group by Marriott International recently launched "Heartbeat of a Destination", a storytelling campaign anchored by a three-part video series that explores Greater China's celebrated destinations through...
FinVolution's BRAVOSHOPS to Boost 1,500 SMEs across Asia, Debuts at UN Global Compact BRI Action Platform Summit
JAKARTA, Indonesia, May 26, 2025 /PRNewswire/ -- FinVolution Group (NYSE: FINV), a leading fintech company, has launched its "BRAVOSHOPS" pilot initiative to support small and micro businesses across pan-Asian countries. The Company introduced the...
Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC
SHANGHAI, May 26, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) announced that its self-developed, highly selective small molecule FGFR4 inhibitor, irpagratinib (ABSK011), has received approval of Breakthrough Therapy Designation from...
World's First -- XellSmart's Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury Officially Approved by the U.S. FDA for a Registrational Phase I Clinical Trial
SUZHOU, China, May 26, 2025 /PRNewswire/ -- In May 2025, XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. officially announced that XellSmart-developed off-the-shelf allogeneic iPSC-derived subtype-specific neural regenerative cell therapy...
Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025
SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray (SZSE: 300760), a leading global developer of healthcare technologies, launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new...
Sporting Goods Industry Unites: Urgent Action Needed to Tackle Physical Inactivity Crisis Projected to Cost $300B by 2030
The global sporting goods industry launched the first-ever Sporting Goods Physical Activity Impact Report: Moving the World Toward an Active Future at an exclusive World Health Assembly side-event in Geneva yesterday The report draws attention to...
Webull Reports First Quarter 2025 Financial Results
Total revenues grew 32% year-over-year to $117 million, reflecting strong account and trading volume growth Customer assets increased 45% year-over-year, driven by increased customer net deposits Disciplined execution alongside robust revenue growth...